Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Fate Therapeutics Inc patents

Recent patent applications related to Fate Therapeutics Inc. Fate Therapeutics Inc is listed as an Agent/Assignee. Note: Fate Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Fate Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Fate Therapeutics Inc-related inventors

Stem cell culture media and methods of enhancing cell survival

The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions. The invention further relates to improved culture media and methods of culturing, processing, modulating, and expanding blood cell products for hematopoietic transplantation.. ... Fate Therapeutics Inc

Genomic engineering of pluripotent cells

Provided are methods and compositions for obtaining genome-engineered ipscs, and derivative cells with stable and functional genome editing at selected sites. Also provided are cell populations or clonal cell lines derived from genome-engineered ipscs, which comprise targeted integration of one or more exogenous polynucleotides, and/or in/dels in one or more selected endogenous genes.. ... Fate Therapeutics Inc

Methods and compositions for inducing hematopoietic cell differentiation

The invention provides culture platforms, cell media, and methods of differentiating pluriptent cells into hematopoietic cells. The invention further provides pluripotent stem cell-derived hematopoietic cells generated using the culture platforms and methods disclosed herein, which enable feed-free, monolayer culturing and in the absence of er formation. ... Fate Therapeutics Inc

Cell culture platform for single cell sorting and enhanced reprogramming of ipscs

The invention provides cell culture conditions for culturing stem cells, including feeder-free conditions for generating and culturing human induced pluripotent stem cells (ipscs). More particularly, the invention provides a culture platform that allows long-term culture of pluripotent cells in a feeder-free environment; reprogramming of cells in a feeder-free environment; single-cell dissociation of pluripotent cells; cell sorting of pluripotent cells; maintenance of an undifferentiated status; improved efficiency of reprogramming; and generation of a naïve pluripotent cell.. ... Fate Therapeutics Inc

Improved reprogramming methods and cell culture platforms

The invention provides compositions and methods for manufacturing pluripotent cells. In particular, the invention provides improved culture platforms for manufacturing pluripotent cells with ground state pluripotency. ... Fate Therapeutics Inc

Enhanced stem cell composition

The invention provides improved methods for cell therapy. In particular, the invention provides therapeutic compositions of enhanced hematopoietic stem and progenitor cells having improved engraftment and homing properties, and methods of making the therapeutic compositions. ... Fate Therapeutics Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Fate Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Fate Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by